Anxiety Disorders

Anxiety disorders are a class of psychiatric conditions defined by excessive, persistent fear, anxiety, or avoidance that is disproportionate to actual threat and produces clinically significant distress or functional impairment.

Anxiety Disorders — clinical overview

What Healing TMS Clinic offers for anxiety: psychiatric medication management for generalized anxiety, panic, and social anxiety; plus, for patients with anxious depression (MDD with comorbid anxious distress), Deep TMS using the BrainsWay system (FDA cleared for anxious depression in 2021). Patients seeking CBT for anxiety are referred to specialty therapists.

Anxiety disorders are a class of psychiatric conditions defined by excessive, persistent fear, anxiety, or avoidance that is disproportionate to actual threat and produces clinically significant distress or functional impairment.1 The DSM-5-TR distinguishes generalized anxiety disorder (GAD), panic disorder, social anxiety disorder (SAD), specific phobias, agoraphobia, and separation anxiety disorder, among others. Twelve-month prevalence in U.S. adults is approximately 19.1% across the class, with lifetime prevalence near 31.1%, making anxiety disorders the most common psychiatric conditions in the United States.2 They are diagnosed clinically by structured interview against DSM-5-TR criteria, not by symptom checklist alone, and frequently co-occur with major depressive disorder.

Recognized signs and symptoms

Generalized anxiety disorder (GAD)

  • Excessive, difficult-to-control worry across multiple domains, most days, ≥6 months
  • Restlessness, fatigue, concentration difficulty, irritability
  • Muscle tension and sleep disturbance

Panic disorder

  • Recurrent unexpected panic attacks (peak intensity within minutes)
  • Palpitations, sweating, trembling, dyspnea, chest discomfort, dizziness, derealization
  • Persistent concern about additional attacks or behavioral change to avoid them

Social anxiety disorder (SAD)

  • Marked fear of social or performance situations involving possible scrutiny
  • Avoidance or endurance with intense distress
  • Out of proportion to actual social threat, ≥6 months

Common across the class

  • Anticipatory anxiety and avoidance behavior
  • Autonomic hyperarousal — tachycardia, GI distress, sleep fragmentation
  • Functional impairment in work, school, or relationships

Diagnostic criteria

Each anxiety disorder has distinct DSM-5-TR criteria with duration thresholds (typically ≥6 months for GAD and SAD, recurrent attacks plus concern for panic disorder), evidence of functional impairment, and exclusion of substance- or medical-cause etiology.1 Validated instruments — GAD-7, PSWQ, Liebowitz Social Anxiety Scale, Panic Disorder Severity Scale — support assessment and outcome tracking but do not replace diagnosis by a qualified clinician. This page is educational and not intended for self-diagnosis.

Treatment options at Healing TMS Clinic

First-line treatment across most anxiety disorders combines evidence-based psychotherapy — particularly cognitive behavioral therapy (CBT) with exposure components — with pharmacotherapy, per APA and NICE guidelines.

  • Medication management — SSRIs (sertraline, escitalopram, paroxetine) and SNRIs (venlafaxine, duloxetine) are first-line. Buspirone is an option for GAD. Benzodiazepines are used selectively and short-term given dependence risk.
  • Evidence-based psychotherapy — CBT, exposure therapy, and mindfulness-based interventions through our referral network.
  • TMS Therapy — for patients whose anxiety co-occurs with treatment-resistant depression, FDA-cleared rTMS targets the same cortico-limbic circuitry implicated in both conditions.

When to consider TMS Therapy

TMS is most commonly indicated for adults whose anxiety co-occurs with treatment-resistant depression. For primary anxiety disorders without depression, TMS is currently considered investigational; coverage outside MDD-based indications is limited. TMS is appropriate to consider when:

  • The patient meets criteria for MDD with significant anxious distress and has failed ≥1–2 antidepressant trials
  • There is no personal history of seizure disorder and no ferromagnetic implants near the treatment coil
  • The patient is medically stable for the standard 6-week outpatient course

For patients with pure anxiety disorders, CBT plus appropriately dosed SSRI/SNRI remains the evidence-based standard. See TMS Therapy for full mechanism, protocol, and safety detail.

Insurance and TMS for anxiety

Insurance coverage for TMS in anxiety is condition-dependent. For MDD with comorbid anxious distress, Medicare and most major commercial carriers provide coverage when standard TRD criteria are met. For primary GAD, panic disorder, or SAD without comorbid TRD, coverage is generally not available outside of clinical-trial settings.

What to expect at your consultation

The initial visit is a structured psychiatric evaluation that distinguishes the specific anxiety disorder, screens for depressive and substance-use comorbidity, and outlines a stepped treatment plan. We serve patients across Anaheim, Orange County, and the broader 30-mile service area. Schedule a consultation to begin.

References


  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Washington, DC: APA Publishing; 2022.  

  2. Kessler RC, Petukhova M, Sampson NA, et al. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012;21(3):169–184. 

A view from a treatment chair — sheer linen curtains lifted by a breeze, a garden beyond, a small steaming cup and a single bud-vase on a walnut side table.

Find out if TMS is right for Anxiety Disorders.

Insurance verification takes about two minutes. We'll tell you whether your plan covers TMS for treatment-resistant depression and what your cost will be — before you book anything.

Monday–Friday, 9:00 AM – 5:00 PM

Call